ClinicalTrialsFinder

Large B-Cell Lymphoma (LBCL) Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma

Large B-Cell Lymphoma (LBCL)
Zhejiang University40 enrolled1 locationNCT04661020